Home Blog Page 1949

Attapeu Approves South Korean Firm for 5-Megawatt Solar Project

By
Thongsavanh Souvannasane
-
On 28 October, Attapeu Province granted a 5-megawatt solar project to a South Korean firm, joining other major solar and wind initiatives in the province.

Attapeu Province has approved a South Korean firm, SBIN Corporation, to develop a 5-megawatt solar power project, adding to the province’s growing portfolio of energy initiatives.

The signing ceremony between Attapeu authorities and the company took place on 28 October at the Provincial Administration Office. 

According to provincial authorities, the project will cover 10 hectares in Sanongmai – Piandong village, Sanamxay district, aiming to promote local socio-economic growth and advance clean energy development.

Details regarding the start of construction have not yet been disclosed.

In addition, Attapeu hosts several other large-scale renewable energy projects.

Meanwhile, Convalt Energy, a US-based renewable energy company, is developing a 1,200-megawatt solar power project in Attapeu with an investment of USD 1.3 billion, covering 1,800 hectares. 

The Project Development Agreement (PDA) was signed in August 2022, and commercial operation is scheduled for late 2027. The company is finalizing its Concession Agreement and preparing for Power Purchase Agreement negotiations with Vietnam Electricity (EVN).

Furthermore, Attapeu, together with neighboring Sekong Province, is part of the 600-megawatt Monsoon Wind Power Project, Southeast Asia’s largest onshore wind farm and Asia’s first cross-border renewable energy venture. Officially launched on 22 August, the USD 950 million project now supplies electricity to Vietnam.

Everest Medicines Acquires Exclusive Greater China and Other Asian Country Rights to VIS-101, a Novel Bifunctional Biologic for Serious Eye Disorders

By
Advertorial Desk
-
  • Everest Medicines acquired an exclusive license to develop, manufacture, and commercialize VIS-101 in Greater China, Singapore, South Korea, and certain Southeast Asian countries.
  • Under the assigned exclusive license, Everest Medicines will make an upfront payment of US$7 million (equivalent to approximately RMB49.7 million) and reimburse up to RMB24.0 million for prior expenses; and pay up to US$89.0 million (equivalent to approximately RMB632.0 million) in potential milestones; plus tied royalties on net sales.
  • VIS-101 is a novel bifunctional biologic targeting VEGF-A and ANG-2 that is more potent and could potentially provide more durable treatment benefits than existing treatments for patients with wet age-related macular degeneration, diabetic macular edema, and retinal vein occlusion. VIS-101 is anticipated to be Phase 3-ready in 2026.
  • By leveraging Everest Medicines’ strong clinical development and commercialization platform, both parties will collaborate closely to efficiently advance the clinical development and commercialization of VIS-101 in China and across Asia, accelerating the delivery of this potentially best-in-class ophthalmology innovative therapy to patients.

SHANGHAI, Oct. 30, 2025 /PRNewswire/ — Everest Medicines (HKEX 1952.HK, “Everest”, or the “Company”), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced that it has acquired an exclusive license with Visara, Inc. (“Visara”), a subsidiary of NovaBridge Biosciences (formerly known as I-Mab, and is a company listed on the Nasdaq Global Market trading under the symbol “NBP”), to secure an exclusive license to develop, manufacture and commercialize VIS-101, in Greater China, Singapore, South Korea and certain Southeast Asian countries.

Under the assigned exclusive license, Everest Medicines will make an upfront payment of US$7 million (equivalent to approximately RMB49.7 million) and reimburse up to RMB24.0 million for prior expenses; and pay up to US$89.0 million (equivalent to approximately RMB632.0 million) in potential milestones; plus tied royalties on net sales.

VIS-101 is a novel bifunctional biologic targeting VEGF-A and ANG-2 that is more potent and could potentially provide more durable treatment benefits than existing treatments for patients with wet age-related macular degeneration, diabetic macular edema, and retinal vein occlusion. VIS-101 has completed initial safety and dose-escalation studies in both the United State of America and China, and is currently completing a randomized, dose-ranging Phase 2 study in China. VIS-101 is anticipated to be Phase 3-ready in 2026.

Globally, the market size for anti-VEGF ophthalmic drugs reached approximately USD 23 billion in 2024 and is projected to exceed USD 40 billion by 2030. In China alone, the prevalent patient population of AMD and DME exceeds 15 million, with around 600,000 new cases each year, yet only about 500,000 patients currently receive treatment. This indicates vast market potential.

“We are pleased to collaborate with Visara. This partnership brings a highly differentiated and commercially attractive asset to Everest’s late-stage product pipeline and marks our entry into ophthalmology, a competitively attractive therapeutic area with significant unmet medical needs,” said Rogers Yongqing Luo, Chief Executive Officer of Everest Medicines. “Leveraging Everest’s clinical development and commercialization expertise, we look forward to advancing VIS-101, a potential best-in-class bifunctional antibody, towards commercialization in China and across Asia.”

“Licensing out Greater China, South Korea and Southeast Asia rights to Everest Medicines is an important step toward streamlining global commercial rights and creating synergy in global clinical development,” said Dr. Sean Fu, Chief Executive Officer of NovaBridge Biosciences. “We are excited to work with Everest Medicines team as a strategic partner.”

“VIS-101 is anticipated to be second-in-class with best-in-class potential, based on bioengineered, superior target neutralizing capabilities,” said Dr. Emmett T. Cunningham, Jr, Co-Founder and Executive Chairman of Visara. “We at Visara and I-Mab are excited to work with Everest to bring VIS-101, a potentially best-in-class multifunction therapeutic for AMD, DME, and RVO, to patients in China and other Asian regions.”

Under its “dual-engine” strategy, Everest Medicines has established a commercialization platform anchored by two blockbuster products targeting high-potential markets and powered by the in-house in vivo CAR-T and mRNA therapeutic cancer vaccine platforms. The Company will continue to focus on key therapeutic areas and new growth markets, with ophthalmology as the next growth driver to strengthen synergy across its core portfolio.

ABOUT VIS-101

VIS-101 is a novel bifunctional biologic targeting VEGF-A and ANG-2 that is more potent and could potentially provide more durable treatment benefits for patients with wet age-related macular degeneration, diabetic macular edema, and retinal vein occlusion than first generation treatment. VIS-101 has completed initial safety and dose-escalation studies in both the United State of America and China, and is currently completing a randomized, dose-ranging Phase 2 study in China. VIS-101 is anticipated to be Phase 3-ready in 2026.

About Everest Medicines

Everest Medicines is a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing transformative pharmaceutical products and vaccines that address critical unmet medical needs for patients in Asian markets. The management team of Everest Medicines has deep expertise and an extensive track record from both leading global pharmaceutical companies and local Chinese pharmaceutical companies in high-quality discovery, clinical development, regulatory affairs, CMC, business development and operations. Everest Medicines has built a portfolio of potentially global first-in-class or best-in-class molecules in the company’s core therapeutic areas of renal diseases, infectious diseases and autoimmune disorders. For more information, please visit its website at www.everestmedicines.com.

ABOUT VISARA

Visara is a clinical-stage biopharmaceutical company focused on developing ophthalmic therapeutics for serious eye disorders. It is a subsidiary of NovaBridge Biosciences, which is a company listed on the Nasdaq Global Market trading under the symbol ”NBP”. NovaBridge Biosciences is a global biotechnology platform company committed to accelerating access to innovative medicines. It combines deep business development expertise with agile translational clinical development to identify, accelerate, and advance breakthrough assets. Its differentiated pipeline is led by givastomig, a potential best-in-class, bispecific antibody (Claudin 18.2 x 4-1BB), and VIS-101, a second-in-class, potentially best-in-class bifunctional biologic, targeting VEGF-A and ANG-2.

Forward-Looking Statements:

This news release may make statements that constitute forward-looking statements, including descriptions regarding the intent, belief or current expectations of the Company or its officers with respect to the business operations and financial condition of the Company, which can be identified by terminology such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” “confident” and similar statements. Such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, or other factors, some of which are beyond the control of the Company and are unforeseeable. Therefore, the actual results may differ from those in the forward-looking statements as a result of various factors and assumptions, such as future changes and developments in our business, competitive environment, political, economic, legal and social conditions. The Company or any of its affiliates, directors, officers, advisors or representatives has no obligation and does not undertake to revise forward-looking statements to reflect new information, future events or circumstances after the date of this news release, except as required by law.

The Reverie Saigon Celebrates a Decade of Extravagance with “Into the Wonder”

By
Advertorial Desk
-

HO CHI MINH CITY, Vietnam, Oct. 30, 2025 /PRNewswire/ — The Reverie Saigon marks ten years as Vietnam’s premier luxury hotel, renowned for its opulent Italian design, world-class service, and status as the country’s only member of The Leading Hotels of the World. Its decade-long excellence is celebrated through numerous international accolades in hospitality and design.

The Reverie Suite bedroom adorned with Provasi interior furnishings
The Reverie Suite bedroom adorned with Provasi interior furnishings

Perfectly located in the golden location of the city, possessing a prime location between Nguyen Hue and Dong Khoi Street, The Reverie Saigon welcomes guests to sumptuous rooms and suites on the uppermost floors of the building, from levels 27 to 39, providing guests with breathtaking views of Saigon, including the river and bustling city, as well as spectacular fireworks displays during festive occasions.

The hotel’s interior resembles an elaborate gallery, featuring exclusive masterpieces that fuse Italian craftsmanship with creative artistry. Central to this collection is the striking five-metre ‘Esmeralda’ sofa by Colombostile, sculpted from precious wood adorned with 24-karat gold leaf and leather, highlighted by an inset amethyst gemstone. The interior also boasts a remarkable three-metre-tall Baldi timepiece, intricately designed from Malachite and weighing one tonne, alongside a grand Bechstein piano embellished with Malachite inlays and gold plating. Designs from renowned architect Philippe Starck and Cassina’s exclusive pieces crafted with the finest leather from Louis Vuitton further elevate the hotel’s decor.

Each standard guestroom is furnished to rival suites in other high-end establishments, while Designer Suites are uniquely styled by individual luxury brands such as Giorgetti, Visionnaire, and Provasi, creating an opulent showcase of Italian art. Artistic elements from Swarovski crystal, mother-of-pearl, and mosaic stone are meticulously hand-inlaid throughout the hotel, enhancing the luxurious ambiance.

At The Reverie Saigon, the philosophy of “one-of-a-kind” luxury is epitomized by crafting unforgettable experiences rather than mere aesthetics. The hotel team adheres to the highest international standards, ensuring meticulous attention to detail, professionalism, and personal intuition that enhance each guest’s stay.

Beyond providing premier accommodation, the hotel enriches experiences with a diverse and refined culinary offering. Guests can explore a variety of restaurants, each reflecting unique architectural styles and culinary essences: Long Trieu, a Michelin-starred Cantonese restaurant; The Long @ Times Square, true to its name, the longest bar in the city, combining Italian influences with innovative cocktails; and Café Cardinal, serving international dishes in a French colonial atmosphere.

One-starred Michelin Long Trieu Restaurant, located inside The Reverie Saigon
One-starred Michelin Long Trieu Restaurant, located inside The Reverie Saigon

The Reverie Saigon delivers a multi-sensory luxury experience—from tactile design and refined acoustics to exquisite cuisine and signature scents. Over the past decade, it has become a symbol of opulent living, defined by bespoke interiors and curated service. Accolades such as the Travel + Leisure Luxury Awards Asia Pacific 2025, World Travel Awards 2024, and TripAdvisor’s Top 10% Hotels globally affirm its status as Saigon’s premier destination for world-class hospitality.

In celebration of the hotel’s 10th anniversary, The Reverie Saigon offers a 10% discount for direct bookings through its website using the code “DIRECT10”.

For more high-resolution photos, click here.

Sany Heavy Industry Co., Ltd.’s Hong Kong IPO: “A+H” Dual Platform Anchors a New Journey of Globalization

By
Advertorial Desk
-

HONG KONG, Oct. 30, 2025 /PRNewswire/ — On October 28, Sany Heavy Industry Co., Ltd. (6031.HK) was officially listed on the Main Board of HKEX (Hong Kong Exchanges and Clearing Limited).

The listing marks a pivotal step in the company’s capital deployment and globalization strategy, coming 21 years after its July 3, 2003, listed on the Shanghai Stock Exchange (600031.SH). It also finalizes the company’s A+H dual-listing framework—a key milestone for its global expansion.

On the morning of the listing, government officials, business partners, intermediaries, and Sany Heavy Industry Co., Ltd.’s management joined the ceremony at HKEX to mark the occasion. At 9:30 a.m., Mr. Xiang Wenbo, Rotating Chairman of SANY Group and Chairman of Sany Heavy Industry Co., Ltd., together with Mr. Yu Hongfu, Director of SANY Group and President of Sany Heavy Industry Co., Ltd., struck the gong at the trading hall, signaling the firm’s entry into international capital markets and the start of a new global growth phase.

At the listing ceremony, Mr. Xiang Wenbo remarked: “Sany Heavy Industry Co., Ltd.’s listing in Hong Kong is both the fulfillment of opportunities and the reward for our relentless efforts. It represents not only the capital market’s recognition of SANY’s high-quality development but also a historic opportunity for Sany Heavy Industry Co., Ltd. to explore broader international financing channels and embrace a larger global market. SANY will leverage Hong Kong, which is a ‘super connector’ for international capital, continue advancing the strategy of globalization, digitalization, and decarbonization. Through innovative technology and outstanding, solid performance, we will reward investors’ trust and support, contribute SANY’s strength to the construction of the international financial center of Hong Kong, and inject SANY’s energy into global sustainable development.”

For the H-share offering, Sany Heavy Industry Co., Ltd. offered approximately 632 million H-shares globally, with a 15% over-allotment option, at an offering price of HKD 21.30 per share. The IPO attracted 21 cornerstone investors, who together subscribed for US$759 million worth of shares. These cornerstone investors include Temasek, BlackRock, Infore Capital, Hillhouse, UBS Asset Management, LMR, RBC GAM, WT, Oaktree Capital, Foresight Fund, Perseverance, Greenwoods, Pinpoint, Ghisallo, Jane Street, Fenghe, Qube, Weichai Power, Dajia Insurance, Fast, and Value Partners, reflecting the strong confidence and high recognition of the international capital market in Sany Heavy Industry Co., Ltd..

Since its founding, Sany Heavy Industry Co., Ltd. has transformed from a single-product, single-market player into a world-class construction machinery firm with diversified offerings, global operations, and a leading market position. This growth was driven by organic expansion, strategic acquisitions, and joint ventures.

Currently, Sany Heavy Industry Co., Ltd. is advancing three core strategies: Globalization, Digitalization, and Decarbonization. Per Frost & Sullivan, it ranks 3rd globally and 1st in China for core construction machinery revenue (2020–2024). During the Track Record Period, products of the company have reached customers in over 150 countries and regions., with 2020–2024 global No.1 rankings in cumulative excavator sales and concrete machinery revenue. Overseas revenue grew at a 15.2% CAGR (2022–2024) and accounted for 57.4% of total sales in the four months ended April 30, 2025.

On Digitalization, Sany Heavy Industry Co., Ltd. uses digital tech to optimize end-to-end manufacturing, operations, and services, upgrading factories to build global competitiveness. As of April 30, 2025, it is the only global construction machinery firm with two World Economic Forum (WEF)-certified Lighthouse Factories—the Beijing Piling Machinery Plant and Changsha No. 18 Plant—serving as industry benchmarks for smart manufacturing.

For Decarbonization, Sany Heavy Industry Co., Ltd. is a leader in low-carbon construction machinery. It launched over 40 new energy product models in 2024, including excavators and mixers, with new energy revenue hitting RMB402.5 million—well above the global industry average contribution ratio. Its electric excavators, electric truck mixers, and electric dump trucks lead China in sales.

With the H-share listing as a catalyst, Sany Heavy Industry Co., Ltd. will deepen its three strategies: expanding global client reach via Globalization, boosting competitiveness through Digitalization, and building sustainability via Decarbonization. Net proceeds from the Global Offering will fund four key areas—global sales/service network expansion, R&D enhancement, overseas manufacturing capacity growth, and working capital replenishment—to support strategy execution and create investor value.

As the global market evolves, Sany Heavy Industry Co., Ltd. is poised to capitalize on global opportunities. It will continue to strengthen its position as a leading global construction machinery firm, driving growth through innovation and strategic expansion.

How Genetron Showcased Test and Measurement Solutions Across Southeast Asia in 2025

By
Advertorial Desk
-

SINGAPORE, Oct. 30, 2025 /PRNewswire/ — Genetron Corp, a regional provider of electrical and electronics test and measurement solutions, concluded a year of active participation across leading engineering events in 2025. Through these engagements, the company strengthened its mission to raise technical awareness and promote practical understanding of testing technologies among engineers and researchers across the region.

Genetron’s Strategic Participation Across Southeast Asia

Genetron showcased its Hardware-in-the-Loop (HIL) applications for Battery Management Systems and Microgrids at 4IR Forum 2025 in Bangkok, supporting Thailand’s Industry 4.0 initiative.
Genetron showcased its Hardware-in-the-Loop (HIL) applications for Battery Management Systems and Microgrids at 4IR Forum 2025 in Bangkok, supporting Thailand’s Industry 4.0 initiative.

In 2025, Genetron attended several key industry events in Malaysia, Thailand, the Philippines, and Singapore, ranging from international conferences and technical symposiums to university-led hackathons and specialised forums. Each platform was carefully selected for its technical depth and relevance to the region’s engineering community.

At these events, the company sponsored manned booths featuring a wide range of test and measurement equipment, including oscilloscopes, protocol analysers, programmable power supplies, and electromagnetic measurement solutions. A major point of interest was the introduction of optically isolated probes, which drew attention from engineers and researchers working with wide bandgap (WBG) semiconductors such as silicon carbide (SiC) and gallium nitride (GaN).

Rather than static product displays, the booths served as interactive learning environments where visitors could engage in real-world demonstrations, ask technical questions, and explore how measurement precision supports innovation in research and design.

PEDS Penang 2025: A Platform for Regional Engagement

Among the events Genetron participated in, PEDS Penang 2025 stood out as a highlight for both audience engagement and technical relevance. With its focus on power electronics and drive systems, the conference aligned with Genetron’s core expertise in testing and validation for advanced energy and mobility applications.

At the event, Genetron showcased complex test systems designed for EV and EVSE charging validation, alongside other high-performance solutions that address the challenges of modern power electronics design. These demonstrations illustrated how engineers can apply precise test and measurement equipment to achieve greater efficiency, reliability, and safety in next-generation energy systems.

Additionally, PEDS attracted a technically proficient audience from across Southeast Asia, representing both academia and industry. This reinforced the company’s role not only as a distributor but also as a technical collaborator offering practical guidance and application insights.

Empowering Engineers Through Expertise and Application

According to Mr John Ong Moh Taur, the Managing Director of Genetron Corp, the overarching theme behind Genetron’s 2025 participation can be summarised as “Better tools make better engineers.” Beyond distribution, Genetron’s focus is on delivering tangible value through technical expertise, hands-on applications support, and cross-brand integration guidance. This approach enables engineers to make the most of advanced electrical and electronics test and measurement equipment, strengthening their capability and confidence.

“Our role goes beyond supplying instruments,” said Mr Ong. “We aim to equip engineers not just with the equipment they need, but also with the knowledge and support they need to apply these tools effectively in solving real-world challenges.”

Genetron’s engagements across SEA reflect its broader mission to empower engineers and elevate technical expertise across the electronics sector. By combining education, demonstration, and collaboration, the company continues to strengthen its regional presence and reinforce its position as a technically driven, value-adding distributor.

Genetron’s Observations: Emerging Trends and Industry Insights

Participating in these regional events also gave Genetron valuable insight into the emerging trends shaping the test and measurement landscape across Southeast Asia:

  • Growth in electric mobility and renewable energy is driving demand for robust, high-accuracy testing solutions.
  • Wider adoption of WBG semiconductors has created a need for advanced probes and isolation systems capable of handling higher voltages and faster switching speeds.
  • Digitalisation and remote testing are becoming standard, with engineers seeking connected, field-friendly tools that enable data monitoring and automation.
  • Practical application support is increasingly valued, as engineers rely on local technical partners who can guide setup, integration, and data interpretation.

These developments reflect a maturing engineering ecosystem—one that increasingly looks beyond purchasing equipment to seek comprehensive, application-driven test and measurement solutions.

What Lies Ahead for Genetron

Looking ahead to 2026, Genetron’s participation strategy will continue to be guided by the insights gained from its engagements this year. The company remains committed to participating in focused, invitation-based events that align with its technical strengths and regional priorities. Each platform will be carefully selected to ensure that every engagement delivers tangible value to partners, customers, and the wider engineering community.

Beyond event participation, several discussions initiated during 2025 are expected to progress into meaningful collaborations. These potential partnerships underscore Genetron’s ongoing efforts to expand its network, share technical expertise, and strengthen its presence across Southeast Asia’s evolving electronics ecosystem.

For more information, visit www.genetroncorp.com.

About Genetron Singapore

Genetron is a leading provider of test and measurement equipment in Singapore, Malaysia, Thailand, the Philippines, Vietnam, and Indonesia. Its product range includes oscilloscopes, protocol analysers, power supplies, electronic loads, and electromagnetic measurement solutions. With a strong emphasis on responsive pre- and post-sales technical support, Genetron partners with engineers and organisations to deliver reliable, data-driven testing solutions that enhance precision, performance, and innovation across industries.

Record Vietnam Rains Kill Seven, Flood 100,000 Homes

By
Phontham Visapra
-
Record Vietnam Rains Kill Seven, Flood 100,000 Homes
A woman wearing a raincoat wades through a flooded street in Hue on 28 October. (Photo by STR / AFP)

Flooding triggered by record heavy rains in central Vietnam this week killed at least seven people and inundated more than 100,000 homes, the environment ministry said on 29 October.

Continue

Innovation in the Spotlight: Microvast at All-Energy Australia 2025

By
Advertorial Desk
-

MELBOURNE, Australia, Oct. 30, 2025 /PRNewswire/ — Microvast Holdings, Inc. (NASDAQ: MVST) (“Microvast”, the “Company” or “we”), a global leader in advanced battery technologies, will showcase its suite of high-performance battery products at All-Energy Australia 2025. The international energy exhibition will be taking place at the Melbourne Convention and Exhibition Centre from October 29 to 30, 2025. At this globally recognized platform, Microvast will present its energy storage solution and a wide range of battery products, demonstrating the company’s recent technological breakthroughs and achievements.

Microvast’s product showcase focuses on meeting the evolving needs of the energy storage sector through its flagship product – the ME6 Energy Storage System (ESS). The ME6 ESS is built on advanced lithium iron phosphate (LFP) battery technology and is specifically engineered to meet the unique requirements of energy storage customers. With its compact footprint, high energy density, and exceptional durability, the ME6 ESS system sets a new benchmark in the energy storage market. The ME6 system delivers up to 10,000 cycles for long-term, reliable energy storage.

In terms of space utilization and safety, the ME6 energy storage system also delivers exceptional performance. With a high energy density design of up to 6 megawatt-hours, the system enables customers to maximize site space and optimize facility layout and infrastructure planning, driving greater efficiency in energy storage deployments. Engineered for reliable operation in challenging environments, the ME6 is equipped with IP55 and C4 protection ratings and an integrated nitrogen protection system, ensuring stable performance in damp, dusty, and harsh conditions. These advanced safety and protection features provide a robust safeguard for large-scale energy storage projects, offering customers confidence and operational peace of mind.

In addition to energy storage solutions, Microvast will present our series of high-energy-density battery products specifically engineered for heavy-duty applications. The lineup features the HpTO-37Ah, MpCO-48Ah, and HpCO-55Ah models, each engineered for exceptional performance in demand industrial environments. These batteries are capable of reaching up to 80% state of charge within just 15–20 minutes, drastically reducing downtime and overcoming operational challenges associated with lengthy charging cycles and extended idle periods. The heavy-duty battery series delivers reliable power delivery and long-term durability, making it ideally suited for the rigorous demands of high-intensity operations such as those in the mining and construction sectors.

For extended-range applications, Microvast will highlight its HnSO-70Ah cell, which delivers an energy density of 295 Wh/kg and a maximum cycle life of up to 4,000 cycles.  This combination makes it an ideal solution for battery electric vehicles (BEVs) and hybrid electric vehicles (HEVs) that demand long endurance and consistent performance. Complementing this is the HnCO-120Ah cell, offering 270 Wh/kg of energy density and an extended cycle life of up to 5,000 cycles.  This high-frequency model provides enhanced durability and a lower total cost of ownership, making it particularly well suited for high-frequency scenarios where long service life and reliability are essential.

Drawing on nearly two decades of expertise in battery technology, Microvast continues to advance its energy storage-focused battery solutions, delivering high-performance,  reliable products that support development of the energy storage industry and accelerate the adoption of clean energy worldwide.

About Microvast

Microvast is a global leader in providing battery technologies for electric vehicles and energy storage solutions. With a legacy of over 19 years, Microvast has consistently delivered cutting-edge battery systems that empower a cleaner and more sustainable future. The Company’s innovative approach and dedication to excellence have positioned it as a trusted partner for customers around the world. Founded in 2006 in Stafford, Texas, Microvast holds more than 810 patents and patent applications that enable solutions for today’s electrification needs.

For more information, please visit www.microvast.com or follow us on LinkedIn (@microvast).

Cautionary Statement Regarding Forward-Looking Statements

This communication contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements about future financial and operating results; our plans, objectives, expectations and intentions with respect to future operations, products and services, including statements with respect to product specifications described herein; and other statements identified by words such as “will likely result,” “are expected to,” “will continue,” “is anticipated,” “estimated,” “believe,” “intend,” “plan,” “projection,” “outlook,” or words of similar meaning. These forward-looking statements include, but are not limited to, statements regarding Microvast’s industry and market sizes, future opportunities for Microvast, and Microvast’s estimated future results. Such forward-looking statements are based upon the current beliefs and expectations of our management and are inherently subject to significant business, economic, and competitive uncertainties, and contingencies, many of which are difficult to predict and generally beyond our control. Actual results and the timing of events may differ materially from the results anticipated in these forward-looking statements.

 

FETC International to Showcase Advanced Smart Mobility and MLFF Technologies at My ASEAN Roads & Traffic Tech Expo 2025

By
Advertorial Desk
-

KUALA LUMPUR, Malaysia, Oct. 30, 2025 /PRNewswire/ — FETC International Co., Ltd., a global leader in Intelligent Transportation Systems (ITS) and Multi-Lane Free Flow (MLFF) tolling solutions, is pleased to announce its participation in the My ASEAN Roads & Traffic Tech Expo (MyARTTE) 2025, to be held from 3–5 November 2025 at MITEC Kuala Lumpur, Malaysia.

FETC International, in partnership with KJS-SEP, successfully implemented a Multi-Lane Free Flow (MLFF) Proof of Concept on the Maju Expressway (E20).
FETC International, in partnership with KJS-SEP, successfully implemented a Multi-Lane Free Flow (MLFF) Proof of Concept on the Maju Expressway (E20).

As Asia’s most innovative conference and exhibition on roads, traffic, and transport technology, MyARTTE 2025 brings together government agencies, infrastructure operators, and technology leaders to discuss advancements shaping the future of mobility in the ASEAN region.

At Booth #2007, FETC International will present its latest innovations in Smart City Solutions and Next-Generation MLFF Highway Systems, featuring insights from its recently completed Proof of Concept (POC) on the Maju Expressway (E20) in Malaysia. Partnering with KJS-SEP, FETC International implemented the system on August 12,2024 and dismantled on August 22, 2025, the POC achieved exceptional performance results, including:

  • Vehicle Detection Rate: 100%
  • ANPR Accuracy Rate: 100%
  • Billed Accuracy Rate: 100%
  • RFID Identification Rate: 99.97%

These achievements demonstrate FETC International’s technical excellence and readiness to support Malaysia’s transition toward efficient, sustainable, and digitally enabled tolling infrastructure.

Roundtable Discussion: The Future of Seamless Mobility Payments

As part of the conference program, Mr. Richard Wu, Vice President of FETC International, will join the Roundtable Discussion titled “The Future of Seamless Mobility Payments” on 4 November 2025, from 11:30 AM to 12:30 PM.

Representing FETC International, Mr. Wu will share insights into the key success factors behind implementing nationwide Multi-Lane Free Flow (MLFF) systems and how they contribute to advancing digital transformation in transportation. He will also highlight FETC International’s latest MLFF projects across several Asian countries.

Driving Smart Mobility in ASEAN

“FETC International is honored to contribute our expertise to MyARTTE 2025, showcasing how proven MLFF solutions can enhance efficiency, transparency, and sustainability in road management,” said Mr. Richard Wu, Vice President of FETC International. “Our successful POC on the Maju Expressway (E20) underscores our commitment to supporting Malaysia’s vision for intelligent, future-ready mobility infrastructure.”

Through innovation and collaboration, FETC International continues to partner with governments and industry stakeholders to shape a connected and intelligent transportation ecosystem across Asia.

Visit FETC International at Booth #2007

FETC International welcomes visitors to Booth #2007 at MyARTTE 2025 to explore the latest advancements in smart transportation technologies and engage in discussions on the future of road infrastructure in Malaysia and ASEAN.

About FETC International

FETC International Co., Ltd. is a global pioneer in Intelligent Transportation Systems (ITS) and Multi-Lane Free Flow (MLFF) tolling solutions. The company delivers comprehensive end-to-end Smart Mobility and Smart Parking solutions that integrate advanced sensing technologies, data analytics, and cloud-based management platforms, enabling operators to optimize efficiency, transparency, and user experience.

Leveraging decades of experience in large-scale electronic toll collection and intelligent transport projects, FETC International is committed to advancing the digital transformation of transportation and enabling sustainable, efficient, and intelligent mobility for all.

1...1,9481,9491,950...6,443Page 1,949 of 6,443